The introduction of GH treatment to treat short stature in TS in the late 1980s marked the beginning of a paradigm shift in the way women with TS are treated both in childhood and adulthood, which was not limited to GH treatment alone. This evidence concerns the gene GH1 and Timothy syndrome.